An interventional study of Vaginal Dinoprostone in Induced Vaginal Delivery, sponsored by University of Alexandria. Completed at 1 site in Egypt. Open to female participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2024-08-19.
Sponsored by University of Alexandria · Not applicable, Interventional, and Treatment
This randomized controlled study was carried out on 370 pregnant women with gestational age ≥ 40 weeks of different ages and parities at El-Shatby Maternity University Hospital after approval of ethical committee of Alexandria Faculty of Medicine. After assessment for eligibility \& enrollment in the study, women were randomly assigned into one of the two study groups, Group (I) received 3 mg vaginal Dinoprostone of maximum 2 doses 6 hours apart and Group (II) received 50 μg of vaginal misoprostol of maximum 2 doses 6 hours apart.
University of Alexandria is the lead sponsor of 59 studies on the registry; 5 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
received 3 mg vaginal Dinoprostone of maximum 2 doses 6 hours apart.
Drug: Vaginal Dinoprostone
received 50μg of vaginal misoprostol of maximum 2 doses 6 hours apart.
Drug: Vaginal Dinoprostone
induction of labour in women with postdate pregnancy with vaginal dinoprostone vs. vaginal misoprostol
Sucess of induction
percentage of women with a successful vaginal delivery
Time frame: number of women who delivered vaginally after induction
Induction to delivery time
time lapse from receiving first dose of induction till delivery of the fetus
Time frame: time from start of induction till delivery of the fetus
Postpartum hemorrhage
quantification of amount of postpartum bleeding
Time frame: after delivery of the placenta
neonatal outcomes
Apgar Score at 1 and 5 minutes
Time frame: at 1 and 5 minutes of delivery
Plan to share: No
No publications or documents are linked to this record.
Ran from Aug 2022 to primary completion in Jul 2023, 11 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Dinoprostone
University of Alexandria